Monoclonal antibody to human thrombopoietin
AssigneeGenentech, Inc.
InventorsDan L. Eaton, Frederic J. de Sauvage
Life of this patent
Estimating the term…
Abstract
Isolated thrombopoietin (TPO), isolated DNA encoding TPO, and recombinant or synthetic methods of preparing and purifying TPO are disclosed. Various forms of TPO are shown to influence the replication, differentiation or maturation of blood cells, especially megakaryocytes and megakaryocyte progenitor cells. Accordingly, these compounds may be used for treatment of thrombocytopenia.
Claims2
A monoclonal antibody that is capable of binding an isolated substantially homogeneous mpl ligand, the mpl ligand consisting of amino acid residues 1 to X of FIG. 1 (SEQ ID NO:1) where X is selected from the group 153, 155, 164, 174, 191, 205, 207, 217, 229, 245, and 332.
Dependencies are inferred from the claim text.